Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Saturday, September 12, 2015 12:29:31 PM
bullish
long term
http://ir.akebia.com/
## source: finance.yahoo.com
Sat, 12 Sep 2015 13:25:41 GMT ~ This Past Week’s Top 5 Biotech Movers
read full: http://247wallst.com/healthcare-business/2015/09/12/this-past-weeks-top-5-biotech-movers/
*********************************************************
Thu, 10 Sep 2015 20:35:08 GMT ~ Akebia (AKBA) Skyrockets on Encouraging Phase II Data
read full: http://finance.yahoo.com/news/akebia-akba-skyrockets-encouraging-phase-203508228.html
*********************************************************
Thu, 10 Sep 2015 20:30:00 GMT ~ Akebia to Present at the 2015 Morgan Stanley Global Healthcare Conference
[Business Wire] - Akebia Therapeutics, Inc. , a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia inducible factor , today announced that John P.
read full: http://finance.yahoo.com/news/akebia-present-2015-morgan-stanley-203000674.html
*********************************************************
Thu, 10 Sep 2015 20:16:03 GMT ~ Akebia Therapeutics Announces Additions to its Management Team
[at noodls] - CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of ...
read full: http://www.noodls.com/view/0DE9291F0ABB56C3C2E48ECAF9A2C7B52FF36D73
*********************************************************
Thu, 10 Sep 2015 20:07:00 GMT ~ 4:07 pm Akebia Therapeutics announces changes to its senior management team; Teresa Compton, PhD joins as Senior Vice President and Chief Scientific Officer
read full: http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#akba
*********************************************************
$AKBA charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$AKBA company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/AKBA/company-info
Ticker: $AKBA
OTC Market Place: Not Available
CIK code: not found
Company name: Akebia Therapeutics, Inc.
Incorporated In:
$AKBA share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$AKBA extra dd links
Company name: Akebia Therapeutics, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=AKBA+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=AKBA+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=AKBA+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/AKBA/news - http://finance.yahoo.com/q/h?s=AKBA+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/AKBA/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/AKBA/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=AKBA+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/AKBA
DTCC (dtcc.com): http://search2.dtcc.com/?q=Akebia+Therapeutics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Akebia+Therapeutics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Akebia+Therapeutics%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/AKBA
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/AKBA/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/AKBA/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=AKBA&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=AKBA
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/AKBA/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=AKBA+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=AKBA+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=AKBA
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=AKBA
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=AKBA+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/AKBA/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=AKBA+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/AKBA.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=AKBA
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/AKBA/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/AKBA
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/AKBA
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/AKBA:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=AKBA
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=AKBA
$AKBA DD Notes ~ http://www.ddnotesmaker.com/AKBA
Recent AKBA News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/13/2024 04:15:10 AM
- Akebia Therapeutics and U.S. Renal Care Initiate the VOICE Trial of Vafseo® (vadadustat) for Patients on Dialysis • PR Newswire (US) • 09/05/2024 12:00:00 PM
- Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 09/03/2024 08:16:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 09/03/2024 08:07:59 PM
- Akebia Therapeutics to Present at Upcoming Investor Conferences • PR Newswire (US) • 08/26/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:52:02 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:06:18 AM
- Akebia Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights • PR Newswire (US) • 08/08/2024 11:00:00 AM
- Akebia Therapeutics to Report Second Quarter 2024 Financial Results and Discuss Recent Business Highlights • PR Newswire (US) • 08/02/2024 12:00:00 PM
- Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 08/01/2024 08:05:00 PM
- Akebia Therapeutics to Present at Upcoming Investor Conferences • PR Newswire (US) • 07/29/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2024 10:05:02 AM
- Akebia Therapeutics Provides Update on Continued Momentum of Commercial Launch of Vafseo® (vadadustat) Tablets • PR Newswire (US) • 07/11/2024 10:00:00 AM
- Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 07/01/2024 08:05:00 PM
- Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference • PR Newswire (US) • 06/27/2024 12:18:00 PM
- Akebia Therapeutics Appoints Erik Ostrowski as Chief Financial Officer and Chief Business Officer • PR Newswire (US) • 06/24/2024 12:58:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 08:20:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 08:20:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 08:19:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:09:32 PM
- Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 06/03/2024 08:05:00 PM
- Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference • PR Newswire (US) • 05/23/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 08:05:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 08:04:58 PM
- Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference • PR Newswire (US) • 05/14/2024 12:00:00 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM